Govt Job for M.Pharm, M.Sc at Regional Centre for Biotechnology

Regional Centre for Biotechnology is an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO.

The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu

Post : Project-JRF position – 01 Post

Title of Project : Deciphering the impact of Time-Restricted Feeding (TRF) as a Neoadjuvant Intervention with Chemotherapy for Cancer Treatment, and its Regulatory Mechanisms.

Duration : Upto 08.07.2022.

Essential Qualifications : M.Sc./MPharm with any National Level Test and experience in mass spectrometry.

Principal Investigator : Dr. Avinash Bajaj, Professor

Fellowship : Rs.31,000/- + 24% HRA per month.

Interested candidates should apply online by 22nd August, 2021, 5:00 PM. The shortlisted candidates will be informed by 25th August, 2021 via email to appear in the online interview to be held at 10:00 AM on 27th August, 2021.

For any query, you may contact PI by email: bajaj@rcb.res.in
Regional Centre for Biotechnology,
3rd Milestone, Faridabad-Gurgaon Expressway
NCR Biotech Science Cluster, Faridabad,
Faridabad (Haryana).

Related Posts

  • Pharma
  • April 19, 2024
  • 20 views
US FDA Mandates Label Updates On CAR-T Cancer Therapies

Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

  • Pharma
  • April 19, 2024
  • 14 views
Karnataka Fails To Take Action Against 1,700 Fake Doctors

Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Mandates Label Updates On CAR-T Cancer Therapies

US FDA Mandates Label Updates On CAR-T Cancer Therapies

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs